Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

December 15, 2017December 15, 2017

Britain Designates Prometic’s IPF Therapy a Promising Innovative Medicine

Idiopathic Pulmonary Fibrosis

British regulators have designated Prometic Life Sciences’ pulmonary fibrosis therapy PBI-4050 a Promising Innovative Medicine, the first step toward allowing some patients to obtain it before it is approved. Prometic developed the oral drug candidate ... Read more

December 13, 2017December 13, 2017

ALCF, Boehringer Ingelheim Bring Gift of Volunteer Help to Lung Cancer Patients

Lung Cancer, News

The Bonnie J. Addario Lung Cancer Foundation (ALCF) and the employees at Boehringer Ingelheim Pharmaceuticals have joined forces to help brighten the holiday season for lung cancer patients through the “Bring Hope ... Read more

November 22, 2017November 22, 2017

PF Foundation Summit Highlights Roles of Care, Research, and Technology

Idiopathic Pulmonary Fibrosis, News

The Pulmonary Fibrosis Foundation’s PFF Summit 2017 Nov. 9-11 in Nashville, Tennessee, recorded an unprecedented number of attendees, including physicians, researchers, patients, caregivers and industry professionals. The lung disease summit takes place ... Read more

November 20, 2017November 20, 2017

FDA Approves Fasenra for Severe Asthma Stemming from Immune Cell Glut

Asthma, News

The U.S. Food and Drug Administration has approved Fasenra (benralizumab) as an add-on maintenance treatment for people 12 years and older with severe asthma. In this case, the authorization is ... Read more

November 15, 2017November 15, 2017

Canadian Association Conducting Purple Challenge Campaign During PH Awareness Month

News, Pulmonary Hypertension

The Pulmonary Hypertension Association of Canada is conducting a Life in Purple Challenge this month as part of its efforts to mark November as Pulmonary Hypertension Awareness Month. The goal is to raise ... Read more

November 14, 2017November 14, 2017

ATS Foundation, Boehringer Ingelheim Fund New Fellowship on IPF Research

Idiopathic Pulmonary Fibrosis, News

The American Thoracic Society (ATS) Foundation and Boehringer Ingelheim have jointly launched a new research fellowship in idiopathic pulmonary fibrosis (IPF), aiming to grant young investigators $100,000 over a two-year period from ... Read more

October 31, 2017October 31, 2017

Lung Microbiome Has Significant Impact on Asthma Severity, Researchers Suggest

Asthma, News

The lung microbiome plays a significant role on asthma severity and patients’ response to treatment, according to researchers at the University of Illinois at Chicago (UIC) College of Medicine. The ... Read more

October 26, 2017October 26, 2017

Early Analysis of Ofev in INPULSIS-ON Trial Shows Long-Term Effectiveness in Treating IPF

News

The therapy Ofev (nintedanib) was shown to slow down the progression of idiopathic pulmonary fibrosis (IPF) through 96 weeks, regardless of a patient’s lung disease severity at the beginning of the study ... Read more

October 23, 2017October 23, 2017

Molecule Produced by Parasitic Worms Could Lead to New Asthma Therapies, Study Suggests

Asthma, News

Researchers have identified a molecule produced by parasitic worms that could aid in the effort to find new therapies for people with asthma, a new study suggests. The study, titled “HpARI Protein ... Read more

October 12, 2017October 13, 2017

Vibativ Displays More Punch Against Bacteria Than Other Antibiotics, Studies Show

Cystic Fibrosis, News, Pneumonia

Vibativ (telavancin) displays more punch against the Staphylococcus aureus bacteria that is involved in lung diseases than other antibiotics it has been tested against, according to presentations in San Diego this month. This ... Read more